Literature DB >> 15517893

UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers.

Tetsuya Oguri1, Toshiaki Takahashi, Mitsuru Miyazaki, Takeshi Isobe, Nobuoki Kohno, Peter I Mackenzie, Yasuhiro Fujiwara.   

Abstract

BACKGROUND: We previously reported that upregulation of glucuronidation activity catalyzed by uridine 5'diphosphoglucuronosyltransferase (UGT) is one of the mechanisms associated with irinotecan hydrochloride/7-ethyl-10-hydroaxycamptothecin (CPT-11/SN-38) resistance. In order to extend this result to the clinical setting, it is important to elucidate the role of SN-38 glucuronidation by UGT1A isoforms in CPT-11/SN-38 resistance in vivo.
MATERIALS AND METHODS: We examined SN-38 glucuronidation activity in COS-7 cells transfected with full-length cDNAs for human UGT isoforms (UGT1A1, UGT1A3, UGT1A6 and UGT1A10). The gene expression levels of UGT isoforms were examined in lung cancer cell lines and 14 lung cancer samples by semi, quantitative RT-PCR.
RESULTS: Our HPLC assay results showed that both UGT1A1 and UGT1A10 are responsible for SN-38 glucuronidation. The levels of UGT1A1 and UGT1A10 expression in a CPT-11/SN-38-resistant cell line were increased compared to levels in the parent cell line. Furthermore, there was considerable intersubject variability in 14 lung cancer samples, but UGT1A1 and UGT1A10 expression levels were significantly correlated (r=0. 70, p=0.004). Our results suggest that not only UGT 1A1, but also UGT 1A10, plays an important role in detoxifying CPT-11/SN-38, leading to resistance to CPT-11/SN-38 in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517893

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.

Authors:  Rene M Balliet; Gang Chen; Ryan W Dellinger; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2009-12-09       Impact factor: 3.922

2.  Hysteresis and Allostery in Human UDP-Glucose Dehydrogenase Require a Flexible Protein Core.

Authors:  Nathaniel R Beattie; Brittany J Pioso; Andrew M Sidlo; Nicholas D Keul; Zachary A Wood
Journal:  Biochemistry       Date:  2018-11-30       Impact factor: 3.162

3.  Pulmonary metabolism of resveratrol: in vitro and in vivo evidence.

Authors:  Satish Sharan; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2013-03-08       Impact factor: 3.922

4.  Allostery and Hysteresis Are Coupled in Human UDP-Glucose Dehydrogenase.

Authors:  Nathaniel R Beattie; Nicholas D Keul; Andrew M Sidlo; Zachary A Wood
Journal:  Biochemistry       Date:  2016-12-22       Impact factor: 3.162

5.  Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.

Authors:  Yongkuan Cao; Guohu Zhang; Peihong Wang; Jun Zhou; Wei Gan; Yaning Song; Ling Huang; Ya Zhang; Guode Luo; Jiaqing Gong; Lin Zhang
Journal:  BMC Gastroenterol       Date:  2017-01-05       Impact factor: 3.067

6.  Conservation of Atypical Allostery in C. elegans UDP-Glucose Dehydrogenase.

Authors:  Nathaniel R Beattie; Nicholas D Keul; Tiffany N Hicks Sirmans; Weston E McDonald; Trevor M Talmadge; Rahil Taujale; Natarajan Kannan; Zachary A Wood
Journal:  ACS Omega       Date:  2019-09-24

Review 7.  Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance.

Authors:  Xiaxia Niu; Ting Wu; Gege Li; Xinsheng Gu; Yanan Tian; Hongmei Cui
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

8.  Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer.

Authors:  Zuyi Ma; Zhenchong Li; Zuguang Ma; Zixuan Zhou; Hongkai Zhuang; Chunsheng Liu; Bowen Huang; Yiping Zou; Zehao Zheng; LinLing Yang; Yuanfeng Gong; Shanzhou Huang; Qi Zhou; Chuanzhao Zhang; Baohua Hou
Journal:  Biomed Res Int       Date:  2021-10-07       Impact factor: 3.411

9.  Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells.

Authors:  Ryan W Dellinger; Harry H Matundan; Amelia S Ahmed; Priscilla H Duong; Frank L Meyskens
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

10.  Analysis of nucleotide diphosphate sugar dehydrogenases reveals family and group-specific relationships.

Authors:  Nicholas Freas; Peter Newton; John Perozich
Journal:  FEBS Open Bio       Date:  2016-01-11       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.